LEARN THE MAIN PRINCIPLES BEHIND A QBD APPROACH AN 2017 - Understanding and Implementing a Quality by Design Program -By AtoZ Compliance

Website http://bit.ly/2puMREb | Edit Freely

Category fda 510k training, us fda 21 cfr part 820, fda medical device training, fda strategic priorities, fda validation training, pharmaceutical compressed air requirements, clinical quality webinars, qbd training, pharmaceutical training, quality by design pharmaceutical, cgmp training

Deadline: May 25, 2017 | Date: May 25, 2017

Venue/Country: Online, U.S.A

Updated: 2017-05-08 19:26:54 (GMT+9)

Call For Papers - CFP

This training will explain the main principles behind a QbD approach and provide guidelines on how to implement the concepts into a pharmaceutical development organization.

Overview:

The benefits of applying the QbD principles in the pharmaceutical industry have been well advertised. Most important are the direct benefits to our primary customer; the patient. Per Janet Woodcock M.D. Director, Center for Drug Evaluation and Research (CDER), Food and Drug Administration “All products are designed and developed to be of high quality; QbD provides a structured framework for developing, documenting and presenting development rationale, experience and knowledge of the formulation and the process, and to ensure manufacture of products consistently fit for patient use.”

Application of these principles can also benefit the pharmaceutical companies by improving manufacturing efficiency and promoting innovation. However, implementing these principles into the pharmaceutical development culture can be challenging. QbD involves a complex set of interactions, technologies and systems that are not easy to grasp.

Why Should You Attend:

Topics covered will include the target product quality profile, risk assessment, methods to establish a design space, and design of a control strategy. This review will help bridge the gap between understanding the principles and practical application.

Areas Covered In This Webinar:

QbD principles discussed include

Quality Target Product Profile (QTPP)

Risk Assessment

Using Models

Design of Experiments

Developing a Design Space

Process Analytical Technology (PAT)

FMEA and Control Plan

Target Operational Profile

Control Strategy

Learning Objectives:

Prepare individuals to better understand the principles behind using QbD to develop a pharmaceutical product

Understand what is meant by Quality be Design

Understand the benefits from applying a QbD approach

Provide key steps to implement a QbD program

Understand what the important tools used to implement a QbD approach

Who Will Benefit:

This course is designed for people tasked with developing, filing, and manufacturing pharmaceutical products especially small molecule oral dosage forms. This includes individuals that have responsibilities for formulation development, scale-up, filing, and commercial manufacture of dosage forms as well as maintaining the high quality of those products. Following personnel will benefit from the course:

Senior quality managers

Quality professionals

Regulatory professionals

Compliance professionals

Production supervisors

Manufacturing engineers

Production engineers

Process owners

Quality engineers

Quality auditors

Development professionals

Senior development managers

Level:

Intermediate

For more information, please visit : http://bit.ly/2puMREb

Email: supportatozcompliance.com

Toll Free: +1- 844-414-1400

Tel: +1-516-900-5509

Speakers Profile :

Steven Laurenz

Steven Laurenz– Chemical Engineering M.S. – Michigan State University

Expertise: Over 25 years of technical leadership experience in product development, process development, technology transfer, and process optimization. Skilled in taking new products from early laboratory stage to successful manufacturing launch. Expert in integrating Quality by Design and risk management into product development. Experience in establishing a Quality System for a R&D Quality Assurance organization.

Experience: Headed product development departments at Abbott Laboratories and AbbVie Inc. Leadership positions in numerous technical consortiums.

Other: Black Belt certified in Business Excellence and Master Certificate in Applied Statistics